News
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
The Associated Press on MSN15d
FDA sets new requirements for COVID vaccines in healthy adults and childrenFederal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...
The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...
The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...
Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results